Results 131 to 140 of about 4,898 (191)

In vitro activity of aztreonam/avibactam and comparators against Enterobacterales isolates from patients with hospital-acquired pneumonia, ventilator-associated pneumonia, and complicated intra-abdominal infections (ATLAS, 2021-2022). [PDF]

J Antimicrob Chemother
Yang Q, Tuon FF, Shah S, Kamat S, Mohamed N, Stone GG, Perez KK, Cantón R.   +7 more
europepmc   +1 more source

Activity of novel antibiotics against dual metallo-Beta-lactamase producing Enterobacter hormaechei clinical isolates. [PDF]

JAC Antimicrob Resist
Solar C, Diaz L, Soto K, Martínez JRW, Canales N, Bergman Y, Peters A, Araos R, García P, Tamma PD, Munita JM.   +10 more
europepmc   +1 more source

Use of Aztreonam-avibactam for infections caused by MBL-producing <i>Enterobacterales</i>. [PDF]

New Microbes New Infect
Medioli F, Bavaro DF, Cento V, Scuderi C, Tordato F, Casana M, Diella L, Cilli A, Morelli P, Varisco B, Della Porta MG, Carlo-Stella C, Vanoni M, Costantini E, Bramanti S, Cecconi M, Bussini L, Bartoletti M.   +17 more
europepmc   +1 more source

<i>In vitro</i> activity of aztreonam-nacubactam and cefepime-nacubactam against a global collection of clinically important Gram-negative Bacilli collected in 2021-2023. [PDF]

JAC Antimicrob Resist
Karlowsky JA, Estabrook M, Suzuki E, Shimizu A, Okade H.   +4 more
europepmc   +1 more source

Vitamin B12 promotes cefiderocol resistance and small-colony variants in carbapenem-resistant <i>Acinetobacter baumannii</i>. [PDF]

mBio
Mezcord V, Luu I, Akhar U, Traglia GM, Rodríguez C, Moheb S, Sanchez SD, Soto MT, Cima Clave MJ, Sieira R, Tuttobene MR, Corso A, Tolmasky ME, Bonomo RA, Actis LA, Rao G, Pasteran F, Ramirez MS.   +17 more
europepmc   +1 more source

In vitro selection of cefiderocol-resistant mutants in Acinetobacter baumannii harbouring the most common carbapenemase genes. [PDF]

J Antimicrob Chemother
Raro OHF, Findlay J, Poirel L, Decousser JW, Nordmann P.   +4 more
europepmc   +1 more source

Understanding mechanisms of reduced cefiderocol susceptibility in pvdS and fecI mutants of Pseudomonas aeruginosa. [PDF]

J Antimicrob Chemother
Yamano Y, Takemura M, Longshaw C, DeJonge BLM, Ishibashi N, Ishii R, Miyagawa D, Nakamura R, Kuroiwa M, Ishioka Y, Adachi T, Rokushima M, Maki H, Sato T.   +13 more
europepmc   +1 more source